Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis

  • RADIUS S.r.l.
  • University “La Sapienza” of Rome

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

A correlation between phenotypical tumor characteristics, quantitative classical immunohistochemistry (IHC), and recurrence score (RS) from Oncotype DX results was used to develop a decision supporting system for clinical use. We created a freely available nomogram based on quantitative IHC results that allows prediction of RS ≤ 25 or ≤ 20. Prospective studies will test this application in clinical practice.
Lingua originaleInglese
pagine (da-a)e600-e611
RivistaClinical Breast Cancer
Volume20
Numero di pubblicazione5
DOI
Stato di pubblicazionePubblicato - 2020

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

  • Oncologia
  • Ricerca sul Cancro

Keywords

  • 80 and over
  • Adjuvant chemotherapy
  • Adult
  • Aged
  • Biomarkers
  • Breast Neoplasms
  • Breast cancer
  • Decision supporting system
  • Estrogen Receptor alpha
  • Female
  • Gene Expression Profiling
  • Genetic Testing
  • Health costs
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen
  • Local
  • Middle Aged
  • Neoplasm Recurrence
  • Nomograms
  • Progesterone
  • Prognosis
  • Quantitative IHC
  • ROC Curve
  • Receptors
  • Retrospective Studies
  • Tumor

Fingerprint

Entra nei temi di ricerca di 'Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis'. Insieme formano una fingerprint unica.

Cita questo